CAS No. 3029184-80-0
Batch:
Purity:99.04
Chemical Structure
Check the
BBO-11818
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
| IUPAC Name | methyl (3S)-3-[[7-(2-amino-3-cyano-7-fluoro-1-benzothiophen-4-yl)-8-fluoro-2-[[(2R,8S)-2-fluoro-1,2,3,5,6,7-hexahydropyrrolizin-8-yl]methoxy]-6-(trifluoromethyl)quinazolin-4-yl]-ethylamino]pyrrolidine-1-carboxylate | |
|---|---|---|
| CAS Number | 3029184-80-0 | |
| Molecular Formula |
C34H33F6N7O3S |
|
| Molecular Weight (MW) | 733.73 | |
| InChIKey | VJMZMAQRBQSNHW-AXZPFCHASA-N |
BBO-11818 is an orally active, non-covalent pan-KRAS inhibitor that binds both active (GTP-bound) and inactive (GDP-bound) states of multiple oncogenic KRAS mutants, including KRAS G12D and G12V. By targeting pan-KRAS, it effectively suppresses downstream MAPK pathway signaling and reduces cell viability in KRAS-driven cancer cell lines. In vivo, BBO-11818 exhibits potent antitumor activity and induces tumor regression in KRAS-mutant xenograft models.
|
Concentration
Volume
Mass
|
|---|
Batch:
All in vitro solubility values are batch-tested experimental data (non-literature values).
| Solvent | Solubility & Note |
|---|---|
| DMSO |
100 mg/mL
(136.28 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 100 mg/mL |
| Water | Insoluble |
Q: Why does a DMSO stock precipitate in media/saline?
A: It is caused by unheated aqueous media (supersaturation), local solvent shock, or incorrect mixing sequence.
How to fix it?
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
Note: Technical data last updated: Sep 1, 2026.